Trastuzumab deruxtecan in previously treated HER2‐positive metastatic or unresectable breast cancer: Real‐life data from the temporary use authorization program in France by Thierry Petit, Nawale Hajjaji, Eric‐Charles Antoine, Marc‐Antoine Benderra, Michel Gozy, Cyril Foa, Jean‐Loup Mouysset, Julien Grenier, Mireille Mousseau, Audrey Mailliez, Mahasti Saghatchian, Emma Lachaier, Isabelle Desmoulins, Audrey Hennequin, Patricia Maes, Delphine Loirat, Francesco Ricci, Véronique Diéras, Dominique Berton, Florence Lai Tiong, Luis Teixeira, Nadine Dohollou, Christelle Lévy, Thomas Bachelot, Jean‐Yves Pierga

Get full text

Impact of the COVID‐19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study by Etienne Guével, Sonia Priou, Guillaume Lamé, Johanna Wassermann, Romain Bey, Catherine Uzan, Gilles Chatellier, Yazid Belkacemi, Xavier Tannier, Sophie Guillerm, Rémi Flicoteaux, Joseph Gligorov, Ariel Cohen, Marc‐Antoine Benderra, Luis Teixeira, Christel Daniel, Barbara Hersant, Christophe Tournigand, Emmanuelle Kempf, the Assistance Publique–Hôpitaux de Paris (AP‐HP) Cancer Group, a Cancer Research Application on Big Data (CRAB) initiative

Get full text